Home
About
Overview
Sharing Data
ORCID
Help
History (55)
Structure and absolute configuration of karlotoxin-2, an ichthyotoxin from the marine dinoflagellate Karlodinium veneficum.
Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction.
The role of perceived threat in the emergence of PTSD and depression symptoms during warzone deployment.
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.
See All 55 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.
Platelet plasminogen activator inhibitor 1 in patients with type II diabetes. Diabetes Care. 1994 Aug; 17(8):818-23.
View in:
PubMed
subject areas
beta-Thromboglobulin
Blood Platelets
Blood Pressure
Cholesterol
C-Peptide
Diabetes Mellitus, Type 2
Diet, Diabetic
Female
Humans
Hypoglycemic Agents
In Vitro Techniques
Male
Middle Aged
Plasminogen Activator Inhibitor 1
Platelet Aggregation
Platelet Factor 4
Reference Values
Triglycerides
authors with profiles
Maria F Lopes-Virella
John A. Colwell